These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 14654905

  • 1. Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites.
    Kuwahara K, Sasaki T, Kobayashi K, Noma B, Serikawa M, Iiboshi T, Miyata H, Kuwada Y, Murakami M, Yamasaki S, Kariya K, Morinaka K, Chayama K.
    Oncol Rep; 2004 Jan; 11(1):73-80. PubMed ID: 14654905
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer.
    Liu CD, Tilch L, Kwan D, McFadden DW.
    J Surg Res; 2002 Jan; 102(1):31-4. PubMed ID: 11792148
    [Abstract] [Full Text] [Related]

  • 3. Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
    Bruns CJ, Shrader M, Harbison MT, Portera C, Solorzano CC, Jauch KW, Hicklin DJ, Radinsky R, Ellis LM.
    Int J Cancer; 2002 Nov 10; 102(2):101-8. PubMed ID: 12385004
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, Crean CD, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.
    Surgery; 2015 Oct 10; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [Abstract] [Full Text] [Related]

  • 8. VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
    Shi Y, Tong M, Wu Y, Yang Z, Hoffman RM, Zhang Y, Tian Y, Qi M, Lin Y, Liu Y, Dai L, Sun Y, Wang Z.
    Anticancer Res; 2013 Feb 10; 33(2):409-17. PubMed ID: 23393331
    [Abstract] [Full Text] [Related]

  • 9. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL.
    Clin Cancer Res; 2006 Mar 15; 12(6):1928-35. PubMed ID: 16551879
    [Abstract] [Full Text] [Related]

  • 10. Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma.
    Solorzano CC, Baker CH, Tsan R, Traxler P, Cohen P, Buchdunger E, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2001 Aug 15; 7(8):2563-72. PubMed ID: 11489840
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.
    Baker CH, Solorzano CC, Fidler IJ.
    Cancer Res; 2002 Apr 01; 62(7):1996-2003. PubMed ID: 11929816
    [Abstract] [Full Text] [Related]

  • 18. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H, Gao W, Li X, Yu L, Luo D, Liu Y, Yu X.
    Pancreatology; 2021 Apr 01; 21(3):589-598. PubMed ID: 33579599
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.
    Akutagawa N, Nishikawa A, Iwasaki M, Fujimoto T, Teramoto M, Kitajima Y, Endo T, Shibuya M, Kudo R.
    Jpn J Cancer Res; 2002 Jun 01; 93(6):644-51. PubMed ID: 12079512
    [Abstract] [Full Text] [Related]

  • 20. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 01; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.